ConductScience.org, home

Paper35141015

5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.

Zhuang Y and 11 others. Am J Cancer Res, 2022. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. 5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity. Papers, record 35141015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35141015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.04
iCite
Revised in PubMed
2022-02-16
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhuang YYuxin
2Yang GGuang
3Wu SShaoyu
4Chen JJianjun
5Guo JJiayin
6Quan DDongling
7Zhang TTingting
8Yang ZZichao
9Tan SShaobin
10Ji YYuheng
11Chen ZZhipeng
12Lv LLin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127620987Microtubule destabilising agents: far more than just antimitotic anticancer drugs.Br J Clin Pharmacol2017https://conductscience.org/library/papers/27620987PubMed
226562752Control of microtubule organization and dynamics: two ends in the limelight.Nat Rev Mol Cell Biol2015https://conductscience.org/library/papers/26562752PubMed
326537178Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis.Eur J Cancer Care (Engl)2017https://conductscience.org/library/papers/26537178PubMed
410071301Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.J Clin Oncol1999https://conductscience.org/library/papers/10071301PubMed
514593726Tubulin and microtubules as targets for anticancer drugs.Prog Cell Cycle Res2003https://conductscience.org/library/papers/14593726PubMed
618783207Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.J Med Chem2008https://conductscience.org/library/papers/18783207PubMed
72009540Mechanism of inhibition of cell proliferation by Vinca alkaloids.Cancer Res1991https://conductscience.org/library/papers/2009540PubMed
818329278Peripheral nerve damage associated with administration of taxanes in patients with cancer.Crit Rev Oncol Hematol2008https://conductscience.org/library/papers/18329278PubMed
915948296Review: tubulin function, action of antitubulin drugs, and new drug development.Cancer Invest2005https://conductscience.org/library/papers/15948296PubMed
1012700769Dynamics and mechanics of the microtubule plus end.Nature2003https://conductscience.org/library/papers/12700769PubMed
1125673085Triple-negative breast cancer in African-American women: disparities versus biology.Nat Rev Cancer2015https://conductscience.org/library/papers/25673085PubMed
1219303656HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD.J Hepatol2009https://conductscience.org/library/papers/19303656PubMed
1316445613A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.Int J Gynecol Cancer2006https://conductscience.org/library/papers/16445613PubMed
1427153208Design of a novel microtubule targeted peptide vesicle for delivering different anticancer drugs.Chem Commun (Camb)2016https://conductscience.org/library/papers/27153208PubMed
1526177395Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.Chem Biol Drug Des2015https://conductscience.org/library/papers/26177395PubMed
1610590893Chemotherapeutic neuropathy.Curr Opin Neurol1999https://conductscience.org/library/papers/10590893PubMed
1715714588Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.Angew Chem Int Ed Engl2005https://conductscience.org/library/papers/15714588PubMed
1828766222Breast Cancer Disparities: Socioeconomic Factors versus Biology.Ann Surg Oncol2017https://conductscience.org/library/papers/28766222PubMed
1918347795Preclinical discovery of ixabepilone, a highly active antineoplastic agent.Cancer Chemother Pharmacol2008https://conductscience.org/library/papers/18347795PubMed
2025385183The contribution of αβ-tubulin curvature to microtubule dynamics.J Cell Biol2014https://conductscience.org/library/papers/25385183PubMed

See all 56 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42816471Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42816471PubMed
36119827Snail induces dormancy in disseminated luminal type A breast cancer through Src inhibition.Am J Cancer Res2022https://conductscience.org/library/papers/36119827PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene
TUBA1B10376PubTator's text mininghttps://conductscience.org/library/genes/10376NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35141015

GET https://conductscience.org/api/papers/v1/35141015/references?page=2